Efficacy of Buzhong Yiqi Decoction in the Treatment of Ocular Myopathy Myasthenia Gravis (MG) Patients with Spleen and Kidney Deficiency Type: a Randomized Controlled Trial
- Conditions
- Ocular myasthenia gravis
- Registration Number
- ITMCTR2200005637
- Lead Sponsor
- Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Meets the diagnostic criteria of Western medicine for myasthenia gravis, as well as the diagnosis and syndrome differentiation criteria of Chinese medicine;
2. Patients classified as ocular myasthenia gravis according to the modified Osserman classification;
3. Aged less than 80 years;
4. After understanding the contents of this study in detail, the patients voluntarily accepted observation and signed the informed consent.
1. Patients with myasthenia gravis receiving high dose of corticosteroids or other immunosuppressive agents;
2. Patients who have had myasthenia crisis or are experiencing myasthenia in the past 1 month;
3. Severe mental disorders cannot cooperate with clinical investigators;
4. Patients with other neuromuscular diseases or peripheral nerve diseases;
5. Patients complicated with serious primary diseases such as cardiovascular, cerebrovascular, respiratory, digestive or endocrine systems, as well as patients complicated with autoimmune diseases or mental illnesses;
6. Pregnant or lactating women and people with allergies.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MG Quality of life 15;the absolute and relative Score of MG, ARS-MG;Integral of TCM Syndrome;
- Secondary Outcome Measures
Name Time Method